Titre:
  • 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Auteur:Lyon, Alexander R; López-Fernández, Teresa; Couch, Liam S; Asteggiano, Riccardo; Aznar, Marianne C; Bergler-Klein, Jutta; Boriani, Giuseppe; Cardinale, Daniela Maria D.; Cordoba, Raul; Cosyns, Bernard; Cutter, David J; de Azambuja, Evandro; de Boer, Rudolf A; Dent, Susan F; Farmakis, Dimitrios; Gevaert, Sofie A; Gorog, Diana A; Herrmann, Joerg; Lenihan, Daniel; Moslehi, Javid; Moura, Brenda; Salinger, Sonja SS; Stephens, Richard; Suter, Thomas M; Szmit, Sebastian; Tamargo, Juan; Thavendiranathan, Paaladinesh; Tocchetti, Carlo G; van der Meer, Peter; van der Pal, Helena J H; Casado Arroyo, Ruben
Informations sur la publication:European heart journal, 43, 41, page (4229-4361)
Statut de publication:Publié, 2022-11-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Amyloid light-chain cardiac amyloidosis
Androgen deprivation therapy
Anthracycline
Arrhythmias
Atrial fibrillation
Biomarkers
Cancer
Cancer survivors
Carcinoid syndrome
Cardiac magnetic resonance
Cardiac tumour
Cardio-oncology
Cardiotoxicity
Chemotherapy
Coronary artery disease
Echocardiography
Fluoropyrimidine
Guidelines
Haematopoietic stem cell transplantation
Heart failure
MeSH keywords:Humans
Radiation Oncology
Medical Oncology
Neoplasms -- drug therapy
Heart
Hematology
Antineoplastic Agents -- therapeutic use
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0195-668X
info:doi/10.1093/eurheartj/ehac244
info:pii/6673995
info:scp/85139297152
info:pmid/36017568